First gene therapy tested for serious kidney disease
Disease control
Recruiting now
This is the first study in humans to test a new gene therapy called PS-002 for adults with IgA nephropathy, a serious kidney disease. The main goal is to see if the treatment is safe and well-tolerated, while also checking for early signs that it might help control the disease. T…
Phase: PHASE1, PHASE2 • Sponsor: Purespring Therapeutics Limited • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC